Since cytotoxic CD8 T cells and T-helper type 1 [Th1] cells have the potential to eliminate cancer cells and to mediate long-term protection from disease (Sallusto et al., 2010), it is important to increase the functions of these anti-cancer T cells in cancer patients. The gene discussed is CD8A; the disease is cancer.